BR112014019526B8 - Forma de dosagem de liberação rápida e seu método de produção - Google Patents

Forma de dosagem de liberação rápida e seu método de produção

Info

Publication number
BR112014019526B8
BR112014019526B8 BR112014019526A BR112014019526A BR112014019526B8 BR 112014019526 B8 BR112014019526 B8 BR 112014019526B8 BR 112014019526 A BR112014019526 A BR 112014019526A BR 112014019526 A BR112014019526 A BR 112014019526A BR 112014019526 B8 BR112014019526 B8 BR 112014019526B8
Authority
BR
Brazil
Prior art keywords
dosage form
production method
release dosage
rapid release
dosage forms
Prior art date
Application number
BR112014019526A
Other languages
English (en)
Other versions
BR112014019526A8 (pt
BR112014019526B1 (pt
BR112014019526A2 (pt
Inventor
H Waldman Joel
Franzoi Fernanda
S Bean Anthony
Original Assignee
Chenango Zero Llc
Mcneil Ppc Inc
Johnson & Johnson Consumer Inc
Chenango Two Llc
Currahee Holding Company Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chenango Zero Llc, Mcneil Ppc Inc, Johnson & Johnson Consumer Inc, Chenango Two Llc, Currahee Holding Company Inc filed Critical Chenango Zero Llc
Publication of BR112014019526A2 publication Critical patent/BR112014019526A2/pt
Publication of BR112014019526A8 publication Critical patent/BR112014019526A8/pt
Publication of BR112014019526B1 publication Critical patent/BR112014019526B1/pt
Publication of BR112014019526B8 publication Critical patent/BR112014019526B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

TABLETES REVESTIDOS DE DESINTEGRAÇÃO RÁPIDA. A presente invenção refere-se a formas de dosagem revestidas que compreendem um núcleo de tablete, de preferência sob forma comprimida, que tem um revestimento sobre sua superfície externa e um ou mais padrões gravados na superfície de tablete. Também são revelados métodos para fabricação de tais formas de dosagem.
BR112014019526A 2012-02-07 2013-02-01 Forma de dosagem de liberação rápida e seu método de produção BR112014019526B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261595767P 2012-02-07 2012-02-07
US61/595,767 2012-02-07
PCT/US2013/024384 WO2013119466A1 (en) 2012-02-07 2013-02-01 Rapidly disintegrating coated tablets

Publications (4)

Publication Number Publication Date
BR112014019526A2 BR112014019526A2 (pt) 2017-06-20
BR112014019526A8 BR112014019526A8 (pt) 2017-07-11
BR112014019526B1 BR112014019526B1 (pt) 2022-04-05
BR112014019526B8 true BR112014019526B8 (pt) 2022-08-30

Family

ID=47720765

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014019526A BR112014019526B8 (pt) 2012-02-07 2013-02-01 Forma de dosagem de liberação rápida e seu método de produção

Country Status (10)

Country Link
US (1) US8900632B2 (pt)
EP (1) EP2811985B1 (pt)
CN (1) CN104114160A (pt)
AU (1) AU2013217564B2 (pt)
BR (1) BR112014019526B8 (pt)
CA (1) CA2862915C (pt)
HK (2) HK1203162A1 (pt)
MX (1) MX359529B (pt)
RU (1) RU2609836C2 (pt)
WO (1) WO2013119466A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA41152A (fr) 2014-12-12 2017-10-17 Johnson & Johnson Consumer Inc Procédé de fabrication de particules de résinate de phényléphrine ; particules de résinate de phényléphrine et utilisation des particules de résinate de phényléphrine dans des formulations pharmaceutiques
CN108888521A (zh) * 2018-05-23 2018-11-27 夏文才 一种药片压制成型及包衣装置
CN111437265A (zh) * 2020-03-20 2020-07-24 苏州医本生命科技有限公司 载药微粒、具有该载药微粒的导管及植入系统
EP4091605A1 (en) 2021-05-19 2022-11-23 G.L. Pharma GmbH Pharmaceutical tablet comprising acetylsalicylic acid
CN115624125B (zh) * 2022-10-28 2024-03-08 广州王老吉大健康产业有限公司 一种泡腾片及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1497044A (en) 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US4543370A (en) 1979-11-29 1985-09-24 Colorcon, Inc. Dry edible film coating composition, method and coating form
US4683256A (en) 1980-11-06 1987-07-28 Colorcon, Inc. Dry edible film coating composition, method and coating form
US4643894A (en) 1984-07-24 1987-02-17 Colorcon, Inc. Maltodextrin coating
US4828841A (en) 1984-07-24 1989-05-09 Colorcon, Inc. Maltodextrin coating
US4873231A (en) 1986-04-08 1989-10-10 Smith Walton J Decreasing the toxicity of an ibuprofen salt
US4802924A (en) 1986-06-19 1989-02-07 Colorcon, Inc. Coatings based on polydextrose for aqueous film coating of pharmaceutical food and confectionary products
US5234099A (en) 1987-02-20 1993-08-10 Mcneil-Ppc, Inc. Coated medicaments and apparatus and methods for making same
US4906478A (en) 1988-12-12 1990-03-06 Valentine Enterprises, Inc. Simethicone/calcium silicate composition
US5275822A (en) 1989-10-19 1994-01-04 Valentine Enterprises, Inc. Defoaming composition
CA2061520C (en) 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
JP3703481B2 (ja) 1992-01-17 2005-10-05 バーウィンド・ファーマスーティカル・サーヴィスィーズ・インコーポレーテッド セルロース重合体およびラクトースに基づくフィルム被覆および被覆組成物
IT1264855B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
US6103260A (en) 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US6274162B1 (en) 2000-01-14 2001-08-14 Bpsi Holdings, Inc. Elegant film coating system
US20040146559A1 (en) * 2002-09-28 2004-07-29 Sowden Harry S. Dosage forms having an inner core and outer shell with different shapes
BR0314547A (pt) * 2002-09-28 2005-08-09 Mcneil Ppc Inc Forma de dosagem com liberação imediata compreendendo invólucro tendo aberturas no mesmo
GB0400452D0 (en) * 2004-01-09 2004-02-11 Norton Healthcare Ltd A pharmaceutical composition
US20070190133A1 (en) * 2004-10-27 2007-08-16 Bunick Frank J Dosage forms having a microreliefed surface and methods and apparatus for their production
CN1785164A (zh) * 2004-12-08 2006-06-14 北京双鹤药业股份有限公司 一种新型的缓控释片剂的制备方法
EP2433621B1 (en) 2006-09-15 2013-05-01 Capsugel Belgium NV Rapidly disintegrating dosage form

Also Published As

Publication number Publication date
AU2013217564A1 (en) 2014-08-21
AU2013217564B2 (en) 2017-04-06
HK1203162A1 (en) 2015-10-23
MX2014009497A (es) 2015-02-04
US20130202700A1 (en) 2013-08-08
RU2609836C2 (ru) 2017-02-06
EP2811985A1 (en) 2014-12-17
CA2862915C (en) 2020-05-26
BR112014019526A8 (pt) 2017-07-11
RU2014136342A (ru) 2016-03-27
CN104114160A (zh) 2014-10-22
CA2862915A1 (en) 2013-08-15
HK1204968A1 (en) 2015-12-11
US8900632B2 (en) 2014-12-02
BR112014019526B1 (pt) 2022-04-05
WO2013119466A1 (en) 2013-08-15
EP2811985B1 (en) 2018-10-17
BR112014019526A2 (pt) 2017-06-20
MX359529B (es) 2018-10-01

Similar Documents

Publication Publication Date Title
BR112013019223A2 (pt) forma de dosagem para liberação modificada, processo para a fabricação de um comprimido e processo para a fabricação de uma forma de dosagem oral
AR114143A2 (es) Formulaciones de comprimidos revestidos
CO2017012362A2 (es) Formas de dosificación sólida que comprenden palbociclib, un ácido hidrosoluble y un portador farmacéuticamente aceptable y métodos para su produccion y uso
HK1252373A1 (zh) 包含含油微膠囊的酸性水性產品及其製造方法
IL239218A0 (en) Atr kinase inhibitor compounds, preparations containing them, their uses and methods for their preparation
ECSP13012825A (es) Tableta oralmente desintegradora
EP3072089A4 (en) Methods, systems, and articles of manufacture for the management and identification of causal knowledge
CL2014003306A1 (es) Preparacion farmaceutica oral que comprende un inhibidor de tirosina quinasa de bruton y forma cristalina a del mismo.
EP2532741A4 (en) INDUCED BLOOD TAMMEL CELLS AND METHOD OF MANUFACTURING THEREOF AND APPLICATIONS OF THESE CELLS
EP2979297A4 (en) Statistical model-based metrology
BR112014026292A2 (pt) comprimido oralmente desintegrável, e, processo para a produção de um comprimido oralmente desintegrável
SG11201500948RA (en) Barrier film, method of making the barrier film, and articles including the barrier film
CL2014002235A1 (es) Proceso para la producción de gas de síntesis de amoníaco y una unidad inicial de una planta de amoníaco.
CL2016000143A1 (es) Comprimido farmacéutico que comprende ácido acetilsalicílico y clopidogrel
BR112014019526B8 (pt) Forma de dosagem de liberação rápida e seu método de produção
EP3051957A4 (en) Chewable product and process for making same
EP3088177A4 (en) Multilayer film, polarization plate, and multilayer film production method
CL2015001741A1 (es) Compuestos a base de yeso que comprende bohemita nanometrica y/o tri hidroxido de aluminio nanometrico; utilizacion de bohemita nanometrica; procedimiento de fabricacion de un elemento de construccion; procedimiento de ignifugado de un producto; y elemento de construccion.
CL2014003055A1 (es) Procedimiento para preparar una composicion farmaceutica que comprende i) proporcionar una primera combinacion que comprende un compuesto inhibidor del proteasoma peptidico, una o mas ciclodextrinas y agua, y ii) poner en contacto la primera combinacion con un acido para formar una segunda combinacion; composicion farmaceutica.
EP2957666A4 (en) Towel product, and manufacturing method for towel product
PL2827726T3 (pl) Wodny produkt zawierający mikrokapsułki zawierające olej oraz sposób ich wytwarzania
CU24178B1 (es) Un sistema y un método para la producción integrada de etanol de primera y segunda generación, que comprende puntos de integración para dicha producción
UY34786A (es) Procedimiento para la fabricación de una forma farmacéutica que comprende nifedipino y candesartan cilexetilo
BR112015022739A2 (pt) processo de fabricação para uma forma de dosagem efervescente
EP3033198A4 (en) Laser systems and methods for internally marking thin layers, and articles produced thereby

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/02/2013, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25A Requested transfer of rights approved

Owner name: CHENANGO ZERO LLC (US)

B25A Requested transfer of rights approved

Owner name: CHENANGO TWO LLC (US)

B25A Requested transfer of rights approved

Owner name: CURRAHEE HOLDING COMPANY INC. (US)

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25A Requested transfer of rights approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)

B25D Requested change of name of applicant approved

Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US)